2007 Yield Pharma successfully applied the patent (CN101220038) of synthesizing EDOT in a new route, and established an EDOT assemble line in Yanchen with a monthly capacity of 5MTs. Yield Pharma’s EDOT was confirmed by ISO9001（UQ070125R0）.

    2006-2007 Yieldpharma developed the synthesizing route of N,N-dimemethylsulfamide in mass production and built up a 1MT-monthly-capacity assemble line in Yancheng. Yield Pharma’s N,N-dimemethylsulfamide was confirmed by ISO9001 as well（UQ070125R0）.

    2008 After finding a new way to synthesize Bosentan intermediates---- 4,6-Dichloro-5-(2-methoxyphenoxy)[2,2']bipyrimidinyl and 5-(2-methoxyphenoxy)-[2,2'-bipyrimidine]-4,6(1h,5h)-dione, Yield Pharma successfully applied a patent（CN101279984）and built up an assemble line with a monthly capacity of 2MTs in Kunshan.

    2009 By removing the ultra-low temperature reaction, Yield Pharma developed a new route in synthesizing pharmaceutical intermediates---- Cyclopropanesulfonyl chloride and Cyclopropane sulfonamide and built up an assemble line with a monthly capacity of 1MT in Kunshan.

    2009 Yield Pharma made a contract with Nanjing University about providing 500 new compounds and established a friendly cooperative relationship.